Published in Virology on May 01, 1978
Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition. J Virol (1982) 3.01
Mapping and identification of the vaccinia virus thymidine kinase gene. J Virol (1982) 2.44
Intermolecular duplexes formed from polyadenylylated vaccinia virus RNA. J Virol (1979) 2.14
Marker rescue of temperature-sensitive mutations of vaccinia virus WR: correlation of genetic and physical maps. J Virol (1983) 1.26
A tandemly-oriented late gene cluster within the vaccinia virus genome. Nucleic Acids Res (1986) 1.20
Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis. J Virol (1978) 1.17
Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication. J Virol (1987) 1.14
Indiscriminate degradation of RNAs in interferon-treated, vaccinia virus-infected mouse L cells. J Virol (1984) 0.84
Some enzymatic activities associated with purified parapoxvirions. J Virol (1983) 0.75
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
Utilization of bacteriophage T7 late promoters in recombinant plasmids during infection. J Mol Biol (1981) 5.66
The achaete-scute gene complex of D. melanogaster: conserved domains in a subset of genes required for neurogenesis and their homology to myc. Cell (1987) 4.43
Molecular genetics of the achaete-scute gene complex of D. melanogaster. Cell (1985) 4.22
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13
Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor. Proc Natl Acad Sci U S A (1989) 3.70
The dsRNA protein kinase PKR: virus and cell control. Biochimie (2007) 3.67
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol (1985) 3.06
The achaete-scute gene complex of Drosophila melanogaster comprises four homologous genes. EMBO J (1988) 3.00
Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods (1995) 2.82
The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology (1994) 2.78
Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis (2000) 2.63
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol (1987) 2.53
Relationship between promoter structure and template specificities exhibited by the bacteriophage T3 and T7 RNA polymerases. Proc Natl Acad Sci U S A (1983) 2.53
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A (1993) 2.44
The expression of three members of the achaete-scute gene complex correlates with neuroblast segregation in Drosophila. Cell (1987) 2.29
Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology (1990) 2.27
Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology (1984) 2.04
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol (1997) 2.00
Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature (1980) 1.95
Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes. J Virol (1998) 1.91
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol (1995) 1.89
Cloning and expression of the bacteriophage T3 RNA polymerase gene. Gene (1986) 1.89
Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J Virol (1987) 1.87
Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol (1992) 1.86
The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J Virol (1993) 1.86
Rapid mutagenesis and purification of phage RNA polymerases. Protein Expr Purif (1997) 1.84
Termination and slippage by bacteriophage T7 RNA polymerase. J Mol Biol (1993) 1.80
Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A (1988) 1.78
Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology (1998) 1.73
Studies of promoter recognition and start site selection by T7 RNA polymerase using a comprehensive collection of promoter variants. Biochemistry (2000) 1.72
Phenocopies induced with antisense RNA identify the wingless gene. Cell (1987) 1.64
Early virus protein synthesis in vaccinia virus-infected cells. J Gen Virol (1973) 1.63
Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus. Nature (1972) 1.63
Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment. J Virol (1997) 1.60
A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus. Virology (1987) 1.59
The specificity loop of T7 RNA polymerase interacts first with the promoter and then with the elongating transcript, suggesting a mechanism for promoter clearance. Proc Natl Acad Sci U S A (2000) 1.55
Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol (1999) 1.54
Structural and functional characterization of a cell surface binding protein of vaccinia virus. J Biol Chem (1990) 1.54
Regulation of promoter selection by the bacteriophage T7 RNA polymerase in vitro. Nucleic Acids Res (1980) 1.52
Characterization of two types of termination signal for bacteriophage T7 RNA polymerase. J Mol Biol (1994) 1.50
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47
Regulation of coliphage T3 and T7 RNA polymerases by the lac repressor-operator system. Gene (1989) 1.46
Sequences of three promoters for the bacteriophage SP6 RNA polymerase. Nucleic Acids Res (1986) 1.45
Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA. Proc Natl Acad Sci U S A (1985) 1.41
Sequence and analysis of the gene for bacteriophage T3 RNA polymerase. Nucleic Acids Res (1985) 1.41
Revised transcription map of the late region of bacteriophage T7 DNA. J Virol (1981) 1.40
Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol (1996) 1.40
Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol (1996) 1.38
A vaccinia virus core protein, p39, is membrane associated. J Virol (1996) 1.37
Regulation of transcription of the late genes of bacteriophage T7. Proc Natl Acad Sci U S A (1978) 1.37
Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology (1997) 1.35
Pausing and termination by bacteriophage T7 RNA polymerase. J Mol Biol (1998) 1.32
Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol (2000) 1.32
Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene. Proc Natl Acad Sci U S A (1986) 1.31
Isolation and characterization of attenuated mutants of vaccinia virus. Virology (1987) 1.30
The synthesis of encephalomyocarditis virus polypeptides in infected L-cells and cell-free systems. Eur J Biochem (1974) 1.28
Specific contacts between the bacteriophage T3, T7, and SP6 RNA polymerases and their promoters. J Biol Chem (1991) 1.27
The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology (1997) 1.26
Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence. J Virol (1987) 1.25
Regulation of cytoplasmic mRNA prevalence in sea urchin embryos. Rates of appearance and turnover for specific sequences. J Mol Biol (1984) 1.25
Studies on the mechanism of entry of vaccinia virus in animal cells. Arch Virol (1987) 1.25
Characterization of halted T7 RNA polymerase elongation complexes reveals multiple factors that contribute to stability. J Mol Biol (2000) 1.24
Derivation of a restriction map of bacteriophage T3 DNA and comparison with the map of bacteriophage T7 DNA. J Virol (1980) 1.24
T7 RNA polymerase mutants with altered promoter specificities. Proc Natl Acad Sci U S A (1993) 1.23
Structure of vaccinia DNA: analysis of the viral genome by restriction endonucleases. Virology (1978) 1.23
Interrupting the template strand of the T7 promoter facilitates translocation of the DNA during initiation, reducing transcript slippage and the release of abortive products. J Mol Biol (2001) 1.22
Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. J Virol (2000) 1.22
Bacteriophage infection: which end of the SP82G genome goes in first? J Virol (1970) 1.22
The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. J Virol (1991) 1.22
Substitution of a single bacteriophage T3 residue in bacteriophage T7 RNA polymerase at position 748 results in a switch in promoter specificity. J Mol Biol (1992) 1.21
Defective vaccinia virus particles in interferon-treated infected cells. Virology (1984) 1.21
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J Virol (1996) 1.20
Mapping of promoter sites utilized by T3 RNA polymerase on T3 DNA. Nucleic Acids Res (1980) 1.18
Structural and functional properties of the 14-kDa envelope protein of vaccinia virus synthesized in Escherichia coli. J Biol Chem (1990) 1.18
Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus. J Virol (1999) 1.17
Hybridization mapping of restriction fragments from the early region of bacteriophage T7 DNA. Virology (1977) 1.16
The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology (1993) 1.16
Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proc Natl Acad Sci U S A (1998) 1.16
The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene (2000) 1.15
A mutant T7 RNA polymerase that is defective in RNA binding and blocked in the early stages of transcription. J Mol Biol (1997) 1.15
Replication of vaccinia DNA in mouse L cells. I. In vivo DNA synthesis. Virology (1977) 1.14
Discrimination between bacteriophage T3 and T7 promoters by the T3 and T7 RNA polymerases depends primarily upon a three base-pair region located 10 to 12 base-pairs upstream from the start site. J Mol Biol (1990) 1.14
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc Natl Acad Sci U S A (1989) 1.14
Characterization of an unusual, sequence-specific termination signal for T7 RNA polymerase. J Biol Chem (1998) 1.14
Abortive initiation by bacteriophage T3 and T7 RNA polymerases under conditions of limiting substrate. Nucleic Acids Res (1989) 1.14
Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology (1997) 1.14
Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus. J Virol (1987) 1.12
Studies on the mechanisms of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis. J Gen Virol (1978) 1.12
Optimization of the hygromycin B resistance-conferring gene as a dominant selectable marker in mammalian cells. Gene (1990) 1.11
Transcription in vitro of T3 DNA by Escherichia coli and T3 RNA polymerases. Analysis of the products in cell-free protein-synthesizing system. Eur J Biochem (1972) 1.11
Uncoating of poxviruses. I. Detection and characterization of subviral particles in the uncoating process. Virology (1972) 1.11
Mutant bacteriophage T7 RNA polymerases with altered termination properties. J Mol Biol (1997) 1.11